Lv21
160 积分 2023-12-19 加入
Efficacy and safety of twice per year depemokimab in chronic rhinosinusitis with nasal polyps (ANCHOR-1 and ANCHOR-2): phase 3, randomised, double-blind, parallel trials
2小时前
待确认
Allergic Rhinitis
8个月前
已完结
Tralokinumab for severe, uncontrolled asthma (STRATOS 1 and STRATOS 2): two randomised, double-blind, placebo-controlled, phase 3 clinical trials
9个月前
已完结
10.1016/S0140-6736(22)02037-2
9个月前
已完结
Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials
9个月前
已完结
A multicentre study assessing the prevalence of sensitizations in patients with asthma and/or rhinitis in China
10个月前
已完结
Blood eosinophil count in the diagnosis of allergic‐like rhinitis with chronic rhinosinusitis
10个月前
已完结
Eosinophils as Major Player in Type 2 Inflammation: Autoimmunity and Beyond
10个月前
已完结
Eosinophils as Major Player in Type 2 Inflammation: Autoimmunity and Beyond
10个月前
已关闭
Eosinophils as Major Player in Type 2 Inflammation: Autoimmunity and Beyond
10个月前
已关闭
皖公网安备34019202002308
